Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV-46046 Dose-Finding Study for Contraception
NCT02817464Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dmpa-sc in contraception (2 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Serum Medroxyprogesterone Acetate (MPA) Concentration at Day 210, Maximum Observed Serum Concentration of MPA and 7 more. Started Oct 2016; status: completed.
02
Drugs
dmpa-sc
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02817464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817464.